SM
Sabby Management’s PharmaCyte Biotech PMCB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-82,373
| Closed | -$178K | – | 64 |
|
|
2023
Q4 | $178K | Sell |
82,373
-14,751
| -15% | -$31.9K | 0.18% | 20 |
|
|
2023
Q3 | $204K | Buy |
+97,124
| New | +$204K | 0.15% | 30 |
|
|
2023
Q1 | – | Sell |
-97,978
| Closed | -$287K | – | 104 |
|
|
2022
Q4 | $287K | Sell |
97,978
-469,622
| -83% | -$1.38M | 0.25% | 33 |
|
|
2022
Q3 | $1.36M | Sell |
567,600
-493,811
| -47% | -$1.18M | 1.72% | 8 |
|
|
2022
Q2 | $2.38M | Sell |
1,061,411
-214,057
| -17% | -$480K | 1.62% | 5 |
|
|
2022
Q1 | $2.93M | Buy |
1,275,468
+57,640
| +5% | +$133K | 0.44% | 4 |
|
|
2021
Q4 | $3.05M | Buy |
1,217,828
+207,682
| +21% | +$519K | 0.44% | 17 |
|
|
2021
Q3 | $3.2M | Buy |
+1,010,146
| New | +$3.2M | 0.43% | 16 |
|